Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ALBUTEROL
- BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
- The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
- Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Compared to Current Propellant.
- A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a New Propellant (HFO) in Participants 40 to 80 Years of Age With COPD
- A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
- Treating Exacerbations of Asthma With Oral Montelukast in Children
- Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD
- A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma
- Geisinger Antibiotic Allergy Pilot Program: Assess and Address
- Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma
- Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting Conditions
- Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation
- Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
- Trial to Determine Effective Aspirin Dose in COPD
- Therapeutic Effect of PBF-680 in Patients With COPD
- Digihaler in Chronic Obstructive Pulmonary Disease (COPD)
- Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.
- Inpatient Penicillin Allergy Delabeling Study
- Tiotropium vs. Inhaled Corticosteroids in Children With Nonatopic Asthma Pilot Study (TioNAAP)
- Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma
- Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype
- This is a Phase 1 Study to Compare Pharmacokinetics of BDA/MDI Compared to Pulmicort Respules in Children With Asthma Aged 4 to 8 Years
- Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90 mcg Per Actuation in Healthy Volunteers Under Fasting Conditions
- Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma Exacerbation
- A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Patients 13 Years or Older With Asthma
- Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD
- Comparison of Potassium Binders in the ER
- Can Anti-asthmatic Medication Improve Sprint Performance in Healthy Endurance Athletes?
- Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma: Distinct Physiological Phenotypes
- A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS)
- Ideal Steroids for Asthma Treatment in the PICU
- A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
- Albuterol and Immune Cell Composition
- A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma
- Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma
- Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Persistent Asthma
- A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately.
- Safety and Efficacy of Albuterol Administered by the Halix™ Dry Powder Inhaler in Subjects With Asthma
- Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity
- Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base
- A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)
- A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Effects of Noninvasive Ventilation Compared to Salbutamol
- Safety and Pharmacokinetics of Halix(TM) Albuterol Unit Dose Disposable Inhaler Versus Albuterol MDI
- Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma
- Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
- Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
- N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome
- Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations
- Effect of Inhaled Albuterol in Pulmonary Hypertension
- Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma
- Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)
- Evaluation on the Efficacy of Bronchodilator Nebulization Via High Flow Nasal Cannula
- A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
- A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease
- An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
- A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma
- Comparison of Albuterol for Status Asthmaticus
- Beta2-mimetic and Central Nervous System
- A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled
- Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
- Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus
- Evaluation of Aerosolized Drugs Deposition During Mechanical Ventilation
- Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults
- Secondhand Smoke Respiratory Health Study
- Aerosolized Albuterol Use in Severe BPD
- Body Composition Changes With Albuterol and Caffeine Versus Placebo in Adolescents
- Changes in the Lung Clearance Index in Pediatric Patients With Asthma
- Asthma in the Elderly: The Effect of Montelukast
- Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
- 24hr Effects of Tiotropium Bromide in Tetraplegia
- Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
- Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease
- Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma
- Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)
- Albuterol to Improve Respiratory Strength in SCI
- Repeat Emergency Department Visits Among Patients With Asthma and COPD
- Magnesium Sulfate to Prevent Hospitalisation of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
- Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
- Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis
- Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children
- Preterm Infant Inhaled Albuterol Dosing
- Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis
- A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Enhancement of Corticosteroid Efficacy in COPD
- An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents W
- A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers
- Nebulized Hypertonic Saline for Inpatient Use in COPD
- A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Bronchodilator Test in Mechanical Ventilated Chronic Obstructive Pulmonary Disease Patients
- Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
- Use of Dexamethasone in Pediatric Asthma Exacerbations
- A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)
- A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso
- Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma
- A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
- Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid Treatment
- Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
- Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate
- A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
- Dipyridamole for Immune Activation in HIV
- Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension
- Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD
- The Various Effects of Gaseous Albuterol on Serum Lactate
- Bronchoreversibility and Radiologic Morphology of Emphysema
- The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia
- Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalization
- Comparison of Nebulizers in ED in Pediatric Asthma Patients
- Dose-Response of Salmeterol in Children
- The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Hav
- Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
- Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease
- Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe Disease
- Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis
- Albuterol in Individuals With Late Onset Pompe Disease (LOPD)
- Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)
- Lung Function Changes of Induced Asthma Children Treated With Inhaled MgSO4
- Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
- Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
- Lung Function of Asthmatic Children by Nebulized MgSO4
- Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)
- Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
- Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics
- Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation
- Safety Study of Albuterol Spiromax® in Subjects With Asthma
- A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium
- An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.
- A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
- Aura Adolescent PK Study GSK2829332
- A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma
- A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD
- Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
- Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
- Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation
- Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
- Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
- Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
- Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
- Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
- A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
- A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPD
- Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment
- Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD
- Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation
- Nebulized Albuterol for Congestive Heart Failure Exacerbation
- Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography
- Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy
- Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients
- Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
- Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Dis
- Antidepressant Treatment at an Inner City Asthma Clinic
- Efficacy and Safety of Increasing Doses of Inhaled Albuterol in Children With Acute Wheezing Episodes
- 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
- 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
- A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD
- A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD
- Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma
- A Study to Evaluate the Integrated Dose Counter on an Albuterol Hydrofluoroalkane (HFA) Metered Dose Inhaler (MDI)
- A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol
- Respiratory Impedance and Obliterative Bronchiolitis
- Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)
- Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma
- Hypertonic Saline for Acute Bronchiolitis
- The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD
- Efficacy of Nebulized Hypertonic Saline in the Treatment of Acute Bronchiolitis
- A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing
- Effect of an Inhaled Glucocorticosteroid (ICS) on Endothelial Dysfunction in Cigarette Smokers
- Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma
- Effect of an Inhaled Glucocorticoid-long-acting Beta Adrenergic Agonist on Endothelial Function in COPD
- Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes
- Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study
- Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006
- PulseHaler Drug Deposition Study in Chronic Obstructive Pulmonary Disease Patients
- Dose-Ranging Study of A006 DPI, in Adult Asthma Patients
- Effect of Nebulized Bronchodilators on Heart Rate
- Characterization of Placebo Responses in Stable Asthma
- Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease
- Bronchodilator Responsiveness in Obliterative Bronchiolitis
- Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
- Effect of Gly16Arg Polymorphism in ADRB2 Gene on Asthma Control in Children Receiving Long Acting Beta Agonists
- Hypertonic Saline as Add on Therapy in Preschool Children With Acute Wheezing Attack.
- A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma
- A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
- Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease
- Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis
- Role of Endorphins in Perception of Dyspnea With Resistive Loading in Chronic Obstructive Pulmonary Disease (COPD)
- Dose-response of Albuterol in Asthmatics
- A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
- 4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma
- Steroids Helping Albuterol Responders Exclusively
- Non-invasive Measures of Effects of Xolair in Asthma
- Use of an Oral Beta-2 Agonist in Persons With Spinal Cord Injury
- Effect of Bronchodilation on Cycle vs Treadmill Exercise Endurance Time in COPD
- Nebulized Budesonide for Children Who Are Hospitalized for Acute Wheezing
- Budesonide for Emergency Treatment of Acute Wheezing in Children
- Viral Inception of Asthma: Prospective Study From Infancy to School-age
- Pharmacogenetics of b2-Agonists in Asthma.
- The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
- Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol
- Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects
- Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD)
- Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma
- Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma
- A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma
- Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma
- CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)
- A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy Volunteers
- A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics
- Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects
- Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma
- Inhaled Corticosteroids Versus Observation for Patients With Decreased Lung Function Status
- Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg
- Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg
- A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults
- Symbicort Onset of Action 2
- Dose-response of Inhaled Formoterol Using Methacholine Challenge as a Bioassay
- Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients
- Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction
- 4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma
- Nebulized Hypertonic Saline for Bronchiolitis
- How Different Beta-2 Receptor Genotypes Affect an Asthmatic's Response to Regular Salmeterol Treatment
- Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
- Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)
- A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation
- Albuterol HFA MDI in Pediatric Participants With Asthma
- Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI
- Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
- Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).
- Nebulized Magnesium Sulfate in Pediatric Asthma
- Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes
- Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
- Montelukast With Status Asthmaticus, Ages 6-18
- Montelukast With Status Asthmaticus, Ages 2-5
- Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)
- A Crossover Study in the Treatment of Patients With COPD
- Assessment of Airway Obstruction in Infants With Lower Respiratory Infections
- Drug Study of Albuterol to Treat Acute Lung Injury
- Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation
- (CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)
- Budesonide Inhalation Suspension for Acute Asthma in Children
- Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department
- Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo
- A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control
- Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome
- Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease
- Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind Study
- Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years
- Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol
- Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma
- Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
- Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)
- The Effect of Nebulized Albuterol on Donor Oxygenation
- Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab
- Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers
- Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma
- Exercise Induced Bronchospasm in Children
- Oral Prednisolone Dosing in Children Hospitalized With Asthma
- Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)
- Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease
- A Pilot Study of Montelukast Sodium (Singulair) in Older Adults With Asthma or Chronic Obstructive Pulmonary Disease
- Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation
- Genetic Determinants of the Bronchodilatation Effect of Albuterol ex-Vivo
- Genetic Determinants of the Response to Salbutamol Among Asthma Patients
- Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
- Continuous Levalbuterol for Treatment of Status Asthmaticus in Children
- Trial of Epinephrine and Albuterol in Bronchiolitis
- Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
- Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
- Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma
- Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
- Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
- Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
- Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma
- Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique
- Treatment of Multiple Sclerosis With Copaxone and Albuterol
- Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)
- A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis
- Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy
- Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
- NHLBI/NICHD Collaborative Studies of Asthma in Pregnancy
- Asthma Clinical Research Network (ACRN)
- Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)
Clinical trials list
click for details